Jay Markowitz - Regeneron Pharmaceuticals Senior Vice President - Portfolio Management

REGN -- USA Stock  

USD 285.89  4.27  1.52%

  President
Dr. Jay S. Markowitz, M.D., serves as Senior Vice President Portfolio Management of the Company. Dr. Markowitz has 15 years of experience as a leading institutional investor and analyst in the biopharmaceutical sector. He was previously at Capital World Investors, where he was a U.S. pharmaceutical and biotechnology analyst and portfolio manager. Dr. Markowitz will work closely with other scientific and development leaders on portfolio evaluation and decision making as well as assessing external opportunities. Prior to Capital World Investors, Dr. Markowitz was a biotechnology analyst and portfolio manager at T. Rowe Price. Before transitioning to an investment career, he was an assistant professor and transplant surgeon at the Johns Hopkins University School of Medicine. Dr. Markowitz received his undergraduate degree from Columbia University and his M.D. from Duke University. He completed a fellowship in transplant surgery at the UCLA Medical Center, a surgical residency at Massachusetts General Hospital, and a Research Fellowship in Cellular and Molecular Immunology at the Harvard School of Public Health.
  President Since 2017      
914-847-7000  http://www.regeneron.com

Management Efficiency

The company has return on total asset (ROA) of 11.57 % which means that it generated profit of $11.57 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 24.43 % meaning that it created $24.43 on every $100 dollars invested by stockholders.
The company currently holds 711.3M in liabilities with Debt to Equity (D/E) ratio of 7.2 indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Regeneron Pharmaceuticals has Current Ratio of 3.8 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

PRESIDENT Since

K RaoDr Reddys Laboratories Ltd
2016
Grainne QuinnPerrigo Company plc
2016
Michael PartridgeVertex Pharmaceuticals Incorpor
N/A
John HendricksonPerrigo Company plc
2016
James MichaudPerrigo Company plc
2016
Catherine KnuppZoetis
2012
Scott JamisonPerrigo Company plc
2011
Louis YuPerrigo Company plc
2013
Ronald JanishPerrigo Company plc
2015
Charles MilsteinVertex Pharmaceuticals Incorpor
2017
Kristin PeckZoetis
2018
Amit SachdevVertex Pharmaceuticals Incorpor
2017
Samiran DasDr Reddys Laboratories Ltd
2016
Heidi ChenZoetis
2012
Kimberly WhiteVertex Pharmaceuticals Incorpor
2018
Paul WeningerPerrigo Company plc
2015
Michael StewartPerrigo Company plc
2004
Thomas GraneyVertex Pharmaceuticals Incorpor
2017
Alok SonigDr Reddys Laboratories Ltd
2015
Sandra BeatyZoetis
2012
Paul SilvaVertex Pharmaceuticals Incorpor
2019

Entity Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for treating various medical conditions worldwide. Regeneron Pharmaceuticals, Inc. was founded in 1988 and is headquartered in Tarrytown, New York. Regeneron Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 7549 people.Regeneron Pharmaceuticals (REGN) is traded on BATS Exchange in USA and employs 7,549 people.

Regeneron Pharmaceuticals Leadership Team

Charles Baker, Independent Director
Joseph Goldstein, Independent Director
Anthony Coles, Independent Director
George Sing, Independent Director
Peter Powchik, Senior Vice President - Clinical Development
Jay Markowitz, Senior Vice President - Portfolio Management
Robert Terifay, Sr. VP of Commercial
Robert Landry, CFO and Sr. VP of Fin.
Michael Brown, Independent Director
Christine Poon, Independent Director
Neil Stahl, Executive VP of RandD
Marion McCourt, Senior Vice President and Head of Commercial
George Yancopoulos, Chief Scientific Officer and President - Regeneron Laboratories, Director
Huda Zoghbi, Director
Bonnie Bassler, Director
Joseph LaRosa, Senior Vice President General Counsel, Secretary
Daniel Plew, Senior Vice President General Manager - Industrial Operations and Product Supply
Leonard Schleifer, President CEO, Director
Alfred Gilman, Independent Director
Roy Vagelos, Chairman of the Board
Michael Aberman, Vice President - Strategy
Manisha Narasimhan, IR Contact
Douglas McCorkle, Vice President Controller, Assistant Treasurer
Marc TessierLavigne, Independent Director
Christopher Fenimore, Vice President Controller
Arthur Ryan, Independent Director

Stock Performance Indicators

Did you try this?

Run Competition Analyzer Now

   

Competition Analyzer

Analyze and compare many basic indicators for a group of related or unrelated entities
All  Next Launch Module

Currently Active Assets on Macroaxis

MSFT   
Purchased over 20 shares of
1 hour ago
Traded for 135.34
VMW   
Purchased a lot of shares of
1 hour ago
Traded for 155.87
GM   
Purchased over 70 shares of
1 hour ago
Traded for 35.56
V   
Purchased few shares of
1 hour ago
Traded for 174.95
CRM   
Purchased a lot of shares of
1 hour ago
Traded for 153.01
Additionally take a look at Your Equity Center. Please also try CEO Directory module to screen ceos from public companies around the world.
Search macroaxis.com